Literature DB >> 2600828

Development of desensitization during repetitive end-plate activity and single end-plate currents in frog muscle.

R A Giniatullin1, G Khamitov, R Khazipov, L G Magazanik, E E Nikolsky, V A Snetkov, F Vyskocil.   

Abstract

1. The amplitudes of end-plate currents (EPCs) in short trains of fifteen to seventeen EPCs at 10 Hz were depressed in the presence of 10 microM-proadifen when acetylcholinesterase (AChE) was inhibited. 2. The proadifen-induced EPC depression was voltage-dependent and the effect was more pronounced at negative membrane potentials. 3. In the presence of proadifen, the mean amplitude of miniature end-plate currents (MEPCs) was reduced by 36% 5 s after the EPC train as compared with MEPCs before the train. 4. Without proadifen, but with inhibited AChE, an increase of temperature from 20 to 26 degrees C and elevation of external Ca2+ from 1.8 to 2.5 mM led to EPC amplitude depression in the train, which was also potential-dependent. 5. After AChE inhibition, proadifen (10 microM) progressively shortened MEPC decay without significant reduction of amplitude up to 40 min of exposition. MEPCs were not affected by proadifen when AChE was active. 6. It is concluded that these postsynaptic effects of proadifen can be explained neither by its action on the resting acetylcholine receptors (AChR) nor on open ion channels but are due to its desensitization-promoting action.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2600828      PMCID: PMC1190566          DOI: 10.1113/jphysiol.1989.sp017606

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  20 in total

1.  ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL.

Authors:  J MONOD; J WYMAN; J P CHANGEUX
Journal:  J Mol Biol       Date:  1965-05       Impact factor: 5.469

2.  A study of the desensitization produced by acetylcholine at the motor end-plate.

Authors:  B KATZ; S THESLEFF
Journal:  J Physiol       Date:  1957-08-29       Impact factor: 5.182

3.  Two distinct kinetic phases of desensitization of acetylcholine receptors of clonal rat PC12 cells.

Authors:  N D Boyd
Journal:  J Physiol       Date:  1987-08       Impact factor: 5.182

4.  On the mechanism of desensitization at cholinergic receptors.

Authors:  H P Rang; J M Ritter
Journal:  Mol Pharmacol       Date:  1970-07       Impact factor: 4.436

5.  A study of desensitization of acetylcholine receptors using nerve-released transmitter in the frog.

Authors:  K L Magleby; B S Pallotta
Journal:  J Physiol       Date:  1981-07       Impact factor: 5.182

Review 6.  Acetylcholine receptor: an allosteric protein.

Authors:  J P Changeux; A Devillers-Thiéry; P Chemouilli
Journal:  Science       Date:  1984-09-21       Impact factor: 47.728

7.  Effect of the desensitization-potentiating agent SKF-525a on frog end-plate currents.

Authors:  L G Magazanik; E Nikolsky; F Vyskocil
Journal:  Eur J Pharmacol       Date:  1982-05-07       Impact factor: 4.432

8.  Drug blockade of open end-plate channels.

Authors:  P R Adams
Journal:  J Physiol       Date:  1976-09       Impact factor: 5.182

9.  The maintenance of resting potentials in glycerol-treated muscle fibres.

Authors:  R S Eisenberg; J N Howell; P C Vaughan
Journal:  J Physiol       Date:  1971-05       Impact factor: 5.182

10.  Reaction of [3H]meproadifen mustard with membrane-bound Torpedo acetylcholine receptor.

Authors:  E B Dreyer; F Hasan; S G Cohen; J B Cohen
Journal:  J Biol Chem       Date:  1986-10-15       Impact factor: 5.157

View more
  14 in total

1.  The effects of sodium nitroprusside on mediator release and the functional properties of postsynaptic membranes in the neuromuscular synapse.

Authors:  A L Zefirov; R R Khaliullina; E M Sokolova; R A Giniatullin
Journal:  Neurosci Behav Physiol       Date:  2000 Sep-Oct

2.  Desensitization shortens the high-quantal-content endplate current time course in frog muscle with intact cholinesterase.

Authors:  R A Giniatullin; M Talantova; F Vyskocil
Journal:  J Physiol       Date:  1997-08-01       Impact factor: 5.182

3.  Altered neurotransmitter release machinery in mice deficient for the deubiquitinating enzyme Usp14.

Authors:  Bula J Bhattacharyya; Scott M Wilson; Hosung Jung; Richard J Miller
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-09       Impact factor: 4.249

4.  Desensitization of the post-synaptic membrane of neuromuscular synapses induced by spontaneous quantum secretion of mediator.

Authors:  R A Giniatullin; L G Magazanik
Journal:  Neurosci Behav Physiol       Date:  1998 Jul-Aug

5.  Repetitive nerve stimulation decreases the acetylcholine content of quanta at the frog neuromuscular junction.

Authors:  L A Naves; W Van der Kloot
Journal:  J Physiol       Date:  2001-05-01       Impact factor: 5.182

6.  Modelling endplate currents: dependence on quantum secretion probability and decay of miniature current.

Authors:  R A Giniatullin; L S Kheeroug; F Vyskocil
Journal:  Eur Biophys J       Date:  1995       Impact factor: 1.733

7.  Transmitter-mediated local contracture of the endplate region of the focally innervated mouse diaphragm treated with anticholinesterase.

Authors:  S J Hong; C C Chang
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

8.  Pre- and postsynaptic effects of the calcium channel blocker verapamil at neuromuscular junctions.

Authors:  E R Sharifullina; R A Afzalov; M V Talantova; F Vyskochil; R A Giniatullin
Journal:  Neurosci Behav Physiol       Date:  2002 May-Jun

9.  The timing of channel opening during miniature endplate currents at the frog and mouse neuromuscular junctions: effects of fasciculin-2, other anti-cholinesterases and vesamicol.

Authors:  W Van der Kloot; O P Balezina; J Molgó; L A Naves
Journal:  Pflugers Arch       Date:  1994-09       Impact factor: 3.657

10.  Role of non-quantal acetylcholine release in surplus polarization of mouse diaphragm fibres at the endplate zone.

Authors:  E E Nikolsky; H Zemková; V A Voronin; F Vyskocil
Journal:  J Physiol       Date:  1994-06-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.